Literature DB >> 89098

CEA and non-specific cross-reacting antigen (NCA) in medullary carcinomas of the thyroid.

P Burtin, C Calmettes, M C Fondaneche.   

Abstract

An immunohistological study of five cases of medullary carcinoma of the thyroid was undertaken with monospecific antisera against CEA and NCA. CEA was present in different areas of the tumors: cell cytoplasm, cell membrane at its apical pole when the tumor had a pseudoglandular organization, deposits in the lumen of pseudoglands, and peri- and extra-cellular deposits. From these extra-cellular deposits, CEA could easily reach the circulation, thus causing rising serum levels up to high values. NCA was found in the same tumors and in the same localizations.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 89098     DOI: 10.1002/ijc.2910230602

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  5 in total

Review 1.  The utility of some modern techniques in understanding thyroid pathology.

Authors:  Virginia A LiVoisi
Journal:  Endocr Pathol       Date:  1990-06       Impact factor: 3.943

2.  Serum tissue polypeptide antigen (TPA) in thyroid cancer.

Authors:  E Martino; G Bambini; F Aghini-Lombardi; E Motz; F Pacini; R Lari; L Baschieri; A Pinchera
Journal:  J Endocrinol Invest       Date:  1984-06       Impact factor: 4.256

3.  Immunohistochemical detection of carcinoembryonic antigen (CEA) in parotid gland carcinomas. Analysis of 52 cases.

Authors:  J Caselitz; T Jaup; G Seifert
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1981

4.  Presence of carcinoembryonic antigen (CEA) in the normal and inflamed human parotid gland. An immunohistochemical study of 31 cases.

Authors:  J Caselitz; G Seifert; T Jaup
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

5.  An investigation of factors influencing serum NCA (non-specific cross-reacting antigen) level in patients with chronic myeloid leukaemia.

Authors:  N Frénoy; M Ben-Bunant; C Berruel; J A Child; M C Gendron; J L Missett; E Razafimahaleo; P Burtin
Journal:  Br J Cancer       Date:  1982-11       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.